Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 18/20 | 0.53 |
| ▸ | ESR1 | P03372 | 9/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.41 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104596 | 0.80 | CYSLTR2 (0.49) | CYP2D6CYSLTR2CYSLTR1 | |
| SCHEMBL7101436 | 0.79 | CYSLTR2 (0.56) | CYSLTR2CYSLTR1 | |
| SCHEMBL2654775 | 0.77 | NPC1 (0.43) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL11611381 | 0.76 | AKR1C3 (0.46) | — | |
| SCHEMBL3541600 | 0.76 | ESR2 (0.54) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL9256924 | 0.75 | IDO1 (0.56) | ESR2ESR1CYP2C9CYP3A4 | |
| SCHEMBL18380615 | 0.75 | CYP2C9 (0.44) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL9256928 | 0.75 | IDO1 (0.56) | ESR2ESR1CYP2C9CYP3A4 | |
| Acetic Acid SCHEMBL6249037 | 0.75 | ESR2 (0.67) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL7098406 | 0.75 | SLC9A1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003095441-A1 | INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | PFIZER INC. (US) | 2003-11-20 | — | — | WO | disclosed |